The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)

Swallow, Diane M ACounsell, Carl E2024-05-082024-05-082023-07Swallow, D M A & Counsell, C E 2023, 'The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)', Journal of Neurology, vol. 270, pp. 3464-3474. https://doi.org/10.1007/s00415-023-11629-x0340-5354ORCID: /0000-0002-0994-3561/work/159955151ORCID: /0000-0001-6622-7839/work/164505658https://hdl.handle.net/2164/23426113969477engSubstantive connection via an eligible employment contractProgressive supranuclear palsyCorticobasal degenerationParkinson’s disease,MisdiagnosisDelayed diagnosisSurvivalR MedicineChief Scientist Office (CSO)Parkinson's UKSupplementary InformationRThe evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)Journal article10.1007/s00415-023-11629-xhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266988/270